Literature DB >> 1867888

The effect of socio-economic conditions on the time of diagnosis and compliance during treatment in growth hormone deficiency.

G Gács1, E Hosszu.   

Abstract

In 78 patients with idiopathic growth hormone (GH) deficiency the effect of the fathers' educational level on the age and the extent of growth retardation at diagnosis was studied. There was a tendency for an increase of the age and the degree of growth retardation with the decrease of the fathers' completed grades. The occurrence of height SD scores less than -4.5 was conversely related to the number of grades completed by the father (chi 2 = 19.2 p less than 0.001). Eighteen of the 70 patients treated with growth hormone discontinued treatment after 0.3 to 6 years. Compliance was closely related to the grades completed by the father (chi 2 = 24.7 p less than 0.001). Six out of 7 patients with a height SDS less than -4.5 at diagnosis and with a father of low level of education (less than 8 grades) became non compliant. It is concluded that the degree of growth retardation at diagnosis and compliance at treatment in GH deficiency is related to the educational level of the father.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1867888

Source DB:  PubMed          Journal:  Acta Paediatr Hung        ISSN: 0231-441X


  3 in total

1.  Exploring Potentially Modifiable Factors That Influence Treatment Non-Adherence Amongst Pediatric Growth Hormone Deficiency: A Qualitative Study.

Authors:  Selina Graham; Vivian Auyeung; John Weinman
Journal:  Patient Prefer Adherence       Date:  2020-10-13       Impact factor: 2.711

2.  Impact of adherence on growth response during the first 2 years of growth hormone treatment.

Authors:  Antonio de Arriba Muñoz; Vanesa Cancela Muñiz; José Juan Alcón Saez; Anunciación Beisti; Enrique Llovet; José Ignacio Labarta Aizpún
Journal:  Endocrine       Date:  2020-12-07       Impact factor: 3.633

Review 3.  Shared Decision-Making in Growth Hormone Therapy-Implications for Patient Care.

Authors:  Carlo L Acerini; David Segal; Sherwin Criseno; Kei Takasawa; Navid Nedjatian; Sebastian Röhrich; Mohamad Maghnie
Journal:  Front Endocrinol (Lausanne)       Date:  2018-11-22       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.